Aurobindo Pharma gets US nod for seizure drug
MUMBAI, Nov 6 (Reuters) - India's Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) said on Friday it secured final approval from the U.S. Food and Drug Administration for Lamotrigine tablets, used in the treatment of partial and generalised seizures.
The drug is the generic equivalent of Lamictal CD tablets, a brand of GlaxoSmithkline (GLAX.BO: Quote, Profile, Research), it said in a statement to the BSE. (Reporting by Tamajit Pain; Editing by Prem Udayabhanu)
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
AIDING GREECE
Eurozone agree in principle to aid Greece - source
Euro zone countries decide to help debt-stricken Greece. Full Article | Video



India
US
UK






